A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 16, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Facial Contouring
Interventions
DRUG

OnabotulinumtoxinA

Intramuscular Injections

DEVICE

JUVÉDERM

Injections

DEVICE

CoolSculpting Elite System

CoolSculpting Elite Applicator

OTHER

SkinMedica Products

Skincare Product

DRUG

KYBELLA

Injections

Trial Locations (10)

10021

RECRUITING

Luxurgery /ID# 270430, New York

22209

RECRUITING

SkinDC /ID# 270411, Arlington

70115

RECRUITING

DelRicht Research - New Orleans 308 /ID# 270425, New Orleans

77388

RECRUITING

Integrated Aesthetics /ID# 270399, Spring

77401

RECRUITING

Bellaire Dermatology Associates /ID# 270429, Bellaire

90277

RECRUITING

Marcus Facial Plastic Surgery /ID# 270408, Redondo Beach

92083-6030

RECRUITING

Pacific Clinical Innovations /ID# 270414, Vista

20037-1495

RECRUITING

Center for Dermatology and Dermatologic Surgery /ID# 270390, Washington D.C.

33146-1837

RECRUITING

Skin Research Institute LLC /ID# 270410, Coral Gables

48009-6301

RECRUITING

Boyd /Id# 270509, Birmingham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY